# About aminopeptides.net — An Independent Research Literature Desk

> About aminopeptides.net: an independent literature digest covering Research Peptide Fundamentals in metabolic and cellular-aging research. Editorial method, scope, and independence statement.

An independent literature digest — calm, encyclopedic, and honest about what the research does and does not show.

## What this desk is

aminopeptides.net is an independent editorial reference for published research on compounds studied in **metabolic and cellular-aging research**. The current scope covers three entries: semaglutide, MOTS-c, and NAD+.

This desk is not a store. It does not sell compounds, supplements, or services. It does not have a clinic or a prescriber. It does not recommend doses or protocols. The content is a literature digest — a curated reading of peer-reviewed science, presented in plain language, with numbered citations linked to a full references list.

It is not affiliated with any manufacturer, compounding pharmacy, academic institution, or healthcare provider. The editorial independence of this desk is unconditional: there is no advertiser, no sponsor, and no commercial relationship that influences what is written here.

## Editorial method

Every factual claim on this desk is grounded in a citation from the peer-reviewed literature or, for regulatory and compliance status, from official sources such as FDA labeling. Citations are numbered in-text (as [N]) and resolved to their full reference on the [references page](/references).

For each compound, the desk reports:
- What the compound is and where it comes from
- Its best-characterized mechanism, based on published research
- What specific studies found, described with the species studied and outcome measured
- Community-reported experiences, clearly labeled **"anecdotal, not clinical evidence"** when present
- Safety and regulatory information from the clinical literature and official sources

Where the evidence is thin, single-lab, or preclinical only, the text says so plainly. Where human data are observational rather than interventional, the distinction is drawn. The desk does not describe animal findings as human findings, and it does not present preliminary evidence as established fact. The aim is an accurate map of the literature — including its gaps.

## Scope, limitations, and independence

This desk covers the metabolic-and-cellular-aging angle on its three member compounds. It is not a comprehensive compendium of all research on any of them — semaglutide alone has generated thousands of publications. The desk selects well-powered or methodologically significant studies, key reviews, and foundational mechanistic work.

Content here is periodically updated as the literature develops, but a literature digest is inherently a snapshot. Readers with clinical, research, or regulatory questions should consult primary sources, licensed healthcare providers, and official regulatory databases (FDA.gov, PubMed.gov).

This site carries no individual author credentials because it is an editorial desk, not a personal blog. Presenting fake authors, fake affiliations, or fake addresses would be misleading, and this desk does not do that. What it does present is a traceable citation for every factual claim — which is more useful than a credential anyway.

---

An independent reading desk for the published biology of metabolic aging — citations, not prescriptions.